Effects of Simvastatin and omega‐3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia
Abstract
Nordøy A, Bønaa KH, Nilsen H, Berge R, Hansen JB, Ingebretsen OC (University of Tromsø, Tromsø, Norway). Effects of Simvastatin and omega‐3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidemia. J Intern Med 1998; 243: 163–70. Objectives .Patients with combined hyperlipidemia are at increased risk for development of coronary heart disease. The purpose of this study was to evaluate the efficiency and the safety of treatment with Simvastatin and omega‐3 fatty acids in patients with this lipid disorder. Design .A double‐blind placebo controlled, randomized study evaluating the effects of Simvastatin separately and in combination with omega‐3 fatty acids in 41 healthy patients with defined hyperlipidemia. After a 16 weeks dietary run‐in period the patients were treated in periods of 5 weeks. Results .As expected Simvastatin (20 mg day−1) reduced serum total cholesterol, triacylglycerols, apolipoproteins B and E and increased HDL‐cholesterol and apolipoprotein A1. Addition of omega‐3 fatty acids (4 g day−1) further decreased serum triacylglycerols (P= 0.007), total cholesterol (P= 0.052) and apolipoprotein E (P= 0.035). No significant changes attributable to supplementation of polyunsaturated fatty acids on the content of lipid peroxides in plasma and in the various lipoprotein fractions were observed. Conclusions .The combined treatment of Simvastatin and omega‐3 fatty acids seems to be an efficient and safe alternative for patients…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 41 participants or records.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.